Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3027401	s-testov	% (%)	118	149	0.00%
3027401	s-testo-v	% (%)	15	15	0.00%
3027401	s-testo,p	% (%)	8	8	0.00%	Distribution not available
3027401	s-testosteroni,vapaa,prosentti	% (%)	8	9	0.00%	Distribution not available
3027401	testosteroni,vapaa,prosentti	% (%)	8	10	0.00%	Distribution not available
3027401	testosteroni,vapaa	% (%)	5	5	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Testicular dysfunction

13.91

13.24

1.3

1.5

1.56

1.40

0.70

Testicular hypofunction

14.18

12.76

1.3

1.5

1.57

1.47

0.41

Other antidepressants

2.72

8.12

1.1

1.2

1.44

1.36

0.70

Exclusions for E4_PCOS_BROAD

6.40

6.61

1.4

1.3

1.61

1.40

0.97

Hypogonadotropic hypogonadism

10.08

6.54

1.5

1.66

1.51

0.50

Hypopituitarism

6.68

5.25

1.5

1.4

1.66

1.41

0.95

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

102

2.55

4.84

1.6

1.1

1.40

1.42

0.08

102

Acute sinusitis

2.38

3.45

1.4

1.1

1.30

1.44

1.02

Continuous positive airway pressure

3.07

3.42

1.1

1.3

1.58

1.29

1.71

Recurrent or chronic depression

2.68

3.17

1.2

1.55

1.39

1.04

Seborrhoeic keratosis

3.71

2.87

1.2

1.1

1.39

1.25

—

Malignant neoplasm of endocrine gland, including Hilmo

6.67

2.86

1.0

1.1

1.40

1.34

—

Other diseases of blood and blood-forming organs

6.01

2.70

1.2

1.6

1.53

1.36

—

Other joint disorders

1.89

2.66

1.3

1.2

1.37

1.38

0.06

Other and unspecified tonsillitis

2.22

2.58

1.2

1.1

1.54

1.47

0.44

Impotence

5.01

2.40

1.3

1.5

1.38

1.41

—

Carbimazole or st.post thyroidectomy, condition for graves disease

4.12

2.36

1.0

1.4

1.47

1.28

—

Malignant neoplasm of endocrine gland

5.56

2.21

1.0

1.1

1.42

1.34

—

Rash and other nonspecific skin eruption

5.56

2.21

1.0

1.7

1.22

1.29

—

Ischaemic heart disease, wide definition

121

0.41

2.13

1.0

1.2

1.38

1.42

—

121

Actinic keratosis

2.76

2.09

1.0

1.2

1.22

1.20

—

Meniscus derangement

1.88

2.00

1.2

1.42

1.39

0.15

Skin changes due to chronic exposure to nonionizing radiation

2.66

2.00

1.0

1.2

1.22

1.21

—

Abnormal results of function studies

4.55

1.94

1.4

1.5

1.54

1.35

—

Subjective visual disturbances

2.96

1.93

1.4

1.3

1.31

1.36

—

Other and unspecified urticaria

3.18

1.88

1.1

1.4

1.53

1.32

—

Achilles tendinitis

3.34

1.74

1.2

1.4

1.47

1.34

—

Other disorders of the musculoskeletal system and connective tissue

3.34

1.74

1.2

1.4

1.43

1.38

—

Other diseases of intestine

3.33

1.74

1.0

1.2

1.32

1.42

—

Paracetamol or NSAID medication

3.78

1.73

2.0

1.1

1.48

1.38

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

3.21

1.73

1.1

1.3

1.34

1.30

—

Spondylosis

1.88

1.73

1.2

1.3

1.30

1.38

0.37

Oxicams

3.06

1.66

1.3

1.2

1.47

1.35

—

Benign paroxysmal vertigo

2.80

1.65

1.0

1.4

1.36

1.32

—

Abnormalities of gait and mobility

3.57

1.61

1.0

1.4

1.20

1.31

—

Injuries to unspecified part of trunk, limb or body region

3.57

1.61

1.0

1.5

1.56

1.38

—

2.37

1.60

1.0

1.2

1.22

—

Deviated nasal septum

1.88

1.54

1.7

1.1

1.37

1.44

0.26

Lesion of ulnar nerve

2.59

1.51

1.0

1.3

1.53

1.36

—

Inguinal hernia, bilateral

2.86

1.50

1.0

1.4

1.40

1.35

—

Inguinal or femoral hernia, bilateral

2.86

1.50

1.0

1.4

1.40

1.35

—

Other skin changes

2.86

1.50

1.0

1.3

1.17

1.30

—

Sensorineural hearing loss

1.67

1.47

1.3

1.2

1.30

1.39

0.54

Other diseases of blood and blood-forming organs, wide

2.50

1.45

1.1

1.3

1.53

1.37

—

Other specific joint derangements/joint disorders

1.66

1.44

1.2

1.49

1.38

0.76

Anti-inflammatory and antirheumatic products, non-steroids

2.71

1.44

1.9

1.2

1.53

1.35

—

FESS (DNB20)

2.73

1.43

1.0

1.4

1.23

1.35

—

Use of pramipexole

2.73

1.43

1.2

1.3

1.43

1.30

—

Pain in joint

1.70

1.37

1.1

1.2

1.44

1.39

0.27

Ethmoidectomy

2.61

1.36

1.0

1.4

1.23

1.38

—

Injury of muscle and tendon at hip and thigh level

2.94

1.36

1.2

1.5

1.56

1.38

—

Use of levodopa decarboxylase inhibitor

2.94

1.36

1.6

1.1

1.18

1.28

—

Other and unspecified iron deficiency

0.00

1.31

0.0

1.2

—

1.28

—

Disorders of thyroid, IBD co-morbidities

2.85

1.25

1.0

1.5

1.28

1.39

—

Vocal cord dysfunction

2.75

1.25

1.4

1.5

1.34

1.18

—

Trigger finger

2.63

1.21

1.4

1.44

1.37

—

Examination and observation for other reasons

0.51

1.19

1.4

1.3

1.43

1.42

—

Malignant neoplasm of respiratory system and intrathoracic organs

0.00

1.17

0.0

1.4

—

1.27

—

Non-selective monoamine reuptake inhibitors

2.07

1.16

1.0

1.3

1.50

1.33

—

Speech therapy

0.00

1.16

0.0

1.3

—

1.37

—

Parkinson's disease, including avohilmo

2.50

1.15

1.6

1.1

1.22

1.26

—

Cerebrovascular diseases

114

0.55

1.11

1.2

1.56

1.36

—

114

Bacterial, viral and other infectious agents

2.38

1.09

1.0

1.4

1.52

1.54

—

Radiculopathy

2.38

1.09

1.0

1.4

1.44

1.39

—

Other disorders of patella

2.38

1.09

1.2

1.3

1.40

1.41

—

Myocardial infarction

0.48

1.08

1.0

1.3

1.18

1.40

—

Major coronary heart disease event excluding revascularizations

0.53

1.06

1.0

1.3

1.26

1.42

—

Iridocyclitis

2.12

1.05

1.4

1.3

1.43

—

Chronic sinusitis

1.79

1.04

1.1

1.36

1.41

0.13

Bacterial, viral and other infectious agents, including avohilmo

2.27

1.03

1.0

1.4

1.52

1.53

—

Pain, not elsewhere classified

1.80

0.96

1.0

1.2

1.33

1.39

—

Cervical disc disorders

1.74

0.96

1.1

1.2

1.53

1.37

1.06

Propionic acid derivatives

2.32

0.95

2.0

1.2

1.57

1.35

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.78

0.95

1.3

1.2

1.43

1.39

0.13

Abnormal spermatozoa

2.22

0.93

1.3

1.55

1.26

—

Spondyloarthritis

2.22

0.93

1.0

1.4

1.57

1.41

—

Dental caries, including avohilmo

1.51

0.91

1.3

1.2

1.43

1.36

0.35

Anterior Iridocyclitis

2.07

0.89

1.3

1.40

1.47

—

Neurological diseases, wide definition

1.91

0.89

1.1

1.3

1.52

1.46

—

Internal derangement of knee

1.65

0.88

1.3

1.2

1.34

1.39

0.33

Blepharochalasis

2.00

0.87

1.0

1.3

1.52

1.28

—

Angina pectoris

0.58

0.85

1.0

1.3

1.28

1.41

—

Myocardial infarction, strict

0.51

0.84

1.0

1.3

1.18

1.39

—

Cholecystectomy

1.57

0.84

1.1

1.2

1.27

1.34

0.23

Varicose veins

1.68

0.83

1.1

1.3

1.31

1.29

0.08

Senile cataract

1.52

0.83

1.2

1.35

1.38

0.18

Acute nasopharyngitis (common cold)

1.86

0.81

1.0

1.2

1.57

1.51

—

All influenza

1.70

0.80

1.1

1.2

1.36

1.41

—

Other enthesopathies

1.70

0.80

1.3

1.49

1.40

—

Stroke, excluding SAH

0.56

0.79

1.3

1.2

1.61

1.34

—

Dialysis, with operation codes

0.00

0.79

0.0

1.4

—

1.43

—

Other disorders of veins

1.67

0.79

1.1

1.3

1.31

1.38

—

Coronary atherosclerosis

104

0.61

0.79

1.1

1.3

1.37

1.43

—

104

Rotator cuff syndrome

1.47

0.78

1.1

1.2

1.38

1.40

0.11

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

0.00

0.78

0.0

1.4

—

1.40

—

Malignant neoplasm of bronchus and lung

0.00

0.78

0.0

1.3

—

1.27

—

Polyuria

1.77

0.76

1.5

1.2

1.38

—

Sequelae with surgical and medical care as external cause

0.00

0.76

0.0

1.3

—

1.37

—

Ischaemic Stroke, excluding all haemorrhages

0.54

0.73

1.3

1.2

1.62

1.33

—

5-aminosalicylic acid

1.75

0.71

1.1

1.4

1.36

1.37

—

Cardiodefibrillation

1.61

0.70

1.2

1.3

1.42

1.29

1.22

Acute and subacute iridocyclitis

1.92

0.70

1.4

1.3

1.36

1.45

—

Coagulation defects, purpura and other haemorrhagic conditions

1.92

0.70

1.2

1.3

1.40

1.34

—

Vasomotor and allergic rhinitis

1.57

0.70

1.2

1.1

1.41

1.43

—

Disorders of vestibular function (Vertigo)

1.56

0.70

1.0

1.3

1.40

1.33

—

Retinal detachments and breaks

1.55

0.69

1.3

1.33

1.31

—

DVT of lower extremities

1.85

0.68

1.6

1.4

1.52

1.41

—

Disease of hard tissues of teeth, NOS

1.51

0.67

1.3

1.1

1.30

1.40

0.35

Renal failure

0.55

0.67

1.2

1.3

1.42

1.33

—

Glucosamine medication

1.64

0.67

1.1

1.3

1.24

1.28

—

Spondylolisthesis/Spondylolysis

1.79

0.66

1.0

1.3

1.46

1.42

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

1.79

0.66

1.4

1.3

1.10

1.44

—

Shoulder lesions

1.37

0.65

1.0

1.2

1.30

1.41

1.00

Soft tissue disorders related to use, overuse and pressure

1.59

0.65

1.3

1.54

1.38

—

Stroke, including SAH

0.60

0.64

1.3

1.2

1.59

1.33

—

Other and unspecified polyneuropathies, also in other diseases

1.72

0.64

1.0

1.4

1.34

1.38

—

Asthma, unspecified (mode)

1.46

0.63

1.1

1.2

1.34

1.41

0.42

Lyme disease, including avohilmo

1.60

0.61

1.1

1.3

1.30

1.37

—

Lyme disease

1.60

0.61

1.1

1.3

1.30

1.37

—

Degeneration of macula and posterior pole

1.58

0.61

1.1

1.3

1.41

1.19

—

Other disorders of eyelid

1.57

0.60

1.0

1.3

1.45

1.25

—

Nephropathy related operations

0.00

0.60

0.0

1.4

—

1.41

—

Diabetic maculopathy, excluding more controls

0.00

0.60

0.0

1.4

—

1.42

—

Pleural effusion

0.00

0.59

0.0

1.3

—

1.29

—

Spirochaetal infections, other/unspecified, including avohilmo

1.54

0.59

1.1

1.3

1.30

1.37

—

Other spirochaetal diseases

1.54

0.59

1.1

1.3

1.30

1.37

—

Abnormal findings on diagnostic imaging of lung

1.50

0.58

1.1

1.3

1.23

1.36

0.74

Problems related to lifestyle

0.00

0.58

0.0

1.2

—

1.47

—

Acute pharyngitis

1.75

0.58

1.2

1.1

1.60

1.45

—

Asthma, unspecified (mode), excluding more controls

1.43

0.57

1.1

1.2

1.34

1.41

0.44

Follow-up examination after treatment for conditions other than malignant neoplasms

0.55

0.57

1.0

1.3

1.52

1.34

—

Peritonsillar abscess

1.67

0.56

1.0

1.1

1.43

1.46

—

Symptoms and signs involving speech and voice

1.67

0.56

1.3

1.32

1.33

—

Polyarthropathies

0.66

0.53

1.0

1.2

1.49

1.38

—

Dysphagia

1.54

0.53

1.5

1.2

1.27

1.33

—

Diseases of arteries, arterioles and capillaries

108

0.68

0.52

1.2

1.30

1.37

—

108

Basal cell carcinoma, including Hilmo

1.54

0.52

1.1

1.3

1.23

1.32

—

Basal cell carcinoma

1.43

0.52

1.0

1.3

1.27

1.31

—

Bacterial pneumoniae

1.49

0.52

1.0

1.2

1.33

1.34

0.06

Diverticular disease of intestine

1.34

0.52

1.2

1.15

1.44

2.70

Glaucoma

1.48

0.51

1.4

1.2

1.45

1.28

1.08

Injury of muscle and tendon at shoulder and upper arm level

1.41

0.50

1.3

1.2

1.25

1.38

1.11

Other soft tissue disorders, not elsewhere classified

106

1.29

0.50

1.2

1.40

1.42

0.09

106

Persons encountering health services for other counselling and medical advice, not elsewhere classified

138

0.77

0.49

1.4

1.2

1.43

1.40

0.17

138

Implicit viral Sepsis, including avohilmo

1.46

0.46

1.3

1.41

1.33

—

Injury, poisoning and certain other consequences of external causes

1.42

0.46

1.5

1.2

1.35

1.46

0.33

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.43

0.46

1.3

1.44

1.24

—

Gonarthrosis

1.32

0.45

1.2

1.45

1.38

0.33

Injury of eye and orbit

1.61

0.43

1.0

1.3

1.72

1.40

—

Acute tubulo-interstitial nephritis

1.39

0.42

1.3

1.2

1.36

1.31

0.24

Non-small cell lung cancer, including Hilmo

0.00

0.41

0.0

1.1

—

1.27

—

Tinnitus

1.52

0.41

1.2

1.3

1.28

1.43

—

Systemic connective tissue disorders

1.52

0.41

1.0

1.4

1.14

1.34

—

Alcohol withdrawal state with delirium

0.00

0.41

0.0

1.5

—

1.33

—

Other viral hepatitis, including avohilmo

0.00

0.41

0.0

1.5

—

1.50

—

Viral hepatitis

0.00

0.41

0.0

1.5

—

1.50

—

Viral hepatitis, including avohilmo

0.00

0.41

0.0

1.5

—

1.50

—

Mental and behavioural disorders due to tobacco

0.00

0.41

0.0

1.5

—

1.33

—

0.00

0.41

0.0

1.4

—

1.32

—

Duodenal ulcer

0.00

0.41

0.0

1.5

—

1.31

—

Infective dermatitis

0.00

0.41

0.0

1.4

—

1.35

—

Other embolism and thrombosis

0.00

0.41

0.0

1.4

—

1.35

—

Smoking dependency

0.00

0.41

0.0

1.4

—

1.35

—

Benign neoplasm: Transverse colon

0.00

0.41

0.0

1.4

—

1.38

—

Candidiasis

0.00

0.41

0.0

1.4

—

1.36

—

Diabetic maculopathy

0.00

0.41

0.0

1.2

—

1.54

—

Cardiac arrest

0.00

0.41

0.0

1.6

—

1.30

—

Eustachian salpingitis and obstruction

0.00

0.40

0.0

1.1

—

1.46

—

Recurrent aphthous stomatitis , including avohilmo

0.00

0.40

0.0

1.4

—

1.35

—

Nasal polyp

1.47

0.40

1.0

1.1

1.44

1.40

—

Implicit viral Sepsis

1.47

0.40

1.2

1.3

1.50

1.31

—

Viral Sepsis

1.47

0.40

1.2

1.3

1.50

1.31

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1.44

0.40

1.1

1.3

1.23

1.32

—

Gonarthrosis, primary, with knee surgery

1.37

0.40

1.2

1.33

1.30

0.08

Alcoholic liver disease

0.00

0.40

0.0

1.3

—

1.39

—

Emotionally unstable personality disorder

0.00

0.40

0.0

1.3

—

1.40

—

Dental operations

1.33

0.39

1.5

1.1

1.47

1.43

0.11

Polyneuropathies and other disorders of the peripheral nervous system

1.43

0.39

1.0

1.3

1.34

1.39

—

Chalazion

0.00

0.39

0.0

1.4

—

1.34

—

Gonarthrosis,primary

112

1.24

0.38

1.2

1.40

1.39

0.02

112

Spinal stenosis

1.36

0.38

1.2

1.3

1.15

1.36

1.04

Colorectal cancer

1.37

0.37

1.2

1.3

1.46

1.30

—

Bacterial pneumonia (organism specified)

1.36

0.36

1.0

1.3

1.33

1.35

0.09

Diseases of the respiratory system

1.32

0.36

1.5

1.2

1.34

1.42

0.24

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.35

0.36

1.3

1.46

1.42

0.17

Hyperplasia of prostate

1.27

0.35

1.2

1.50

1.43

0.34

Sulfasalazine

1.43

0.35

1.0

1.3

1.72

1.34

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.43

0.35

1.3

1.1

1.20

1.42

—

Diseases of pulp and periapical tissues and dental caries

1.28

0.34

1.4

1.2

1.45

1.36

0.37

Impingement syndrome of shoulder

1.33

0.33

1.0

1.2

1.35

1.34

—

Presence of cardiac and vascular implants and grafts

0.68

0.33

1.2

1.40

1.31

—

Pain in limb

103

1.23

0.33

1.2

1.40

0.01

103

Aortic aneurysm

1.28

0.32

1.3

1.33

1.32

—

Benign lipomatous neoplasm

1.28

0.32

1.3

1.57

1.40

—

Malaise and fatigue

0.72

0.31

1.0

1.2

1.25

1.36

—

Diseases of oral cavity, salivary glands and jaws

1.29

0.29

1.5

1.1

1.47

1.40

0.21

Presence of other functional implants

1.27

0.28

1.3

1.2

1.35

1.32

0.12

Coxarthrosis [arthrosis of hip](FG)

0.76

0.28

1.1

1.2

1.57

1.35

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1.23

0.27

1.0

1.3

1.30

1.32

—

Cholelithiasis

1.22

0.27

1.1

1.2

1.31

1.33

0.07

Disorders of lens

1.21

0.27

1.2

1.39

1.41

0.09

Atrial fibrillation and flutter with reimbursement

0.68

0.27

1.2

1.3

1.42

—

DVT of lower extremities and pulmonary embolism

1.21

0.26

1.4

1.2

1.49

1.35

—

Cerebrovascular diseases (FINNGEN)

1.19

0.25

1.2

1.3

1.56

1.42

—

COPD

0.74

0.24

1.0

1.3

1.32

1.31

—

Diabetic retinopathy, excluding more controls

1.27

0.23

1.4

1.2

1.58

1.55

—

Fibroblastic disorders

1.28

0.23

1.4

1.3

1.58

1.32

—

Glaucoma suspect

1.28

0.23

1.4

1.3

1.48

1.29

—

Diabetes mellitus in pregnancy

0.00

0.22

0.0

1.0

—

1.24

—

Colorectal cancer, including Hilmo

1.23

0.22

1.2

1.4

1.46

1.32

—

Intracranial injury

108

1.21

0.22

1.4

1.2

1.42

1.37

0.21

108

Non-small cell lung cancer

0.00

0.21

0.0

1.2

—

1.31

—

Gestational diabetes (for exclusion)

0.00

0.21

0.0

1.0

—

1.14

—

Bicipital tendinitis

0.00

0.21

0.0

1.6

—

1.29

—

Ingrowing nail

0.00

0.21

0.0

1.6

—

1.56

—

Extracorporeal dialysis

0.00

0.21

0.0

1.6

—

1.38

—

Cysts of oral region, not elsewhere classified

0.00

0.21

0.0

1.6

—

1.45

—

Desensitization to allergens

0.00

0.21

0.0

1.6

—

1.43

—

Acute lymphadenitis

0.00

0.21

0.0

1.6

—

1.58

—

Viral hepatitis, IBD co-morbidity

0.00

0.21

0.0

1.6

—

1.43

—

Focal brain injury

0.00

0.21

0.0

1.8

—

1.19

—

Thrombocytopenia, unspecified

0.00

0.21

0.0

1.6

—

1.28

—

Hypoglycaemia, other or unspecified

0.00

0.21

0.0

1.6

—

1.45

—

Fibrosis and cirrhosis of liver

0.00

0.21

0.0

1.5

—

1.30

—

Chronic suppurative otitis media, including avohilmo

0.00

0.21

0.0

1.6

—

1.35

—

Cardiomyopathy, other and unspecified

0.00

0.21

0.0

1.6

—

1.39

—

Spontaneous rupture of synovium and tendon

0.00

0.21

0.0

1.6

—

1.23

—

Other congenital malformations of skin, including avohilmo

0.00

0.21

0.0

1.5

—

1.48

—

Other and unspecified injuries of lower leg

0.00

0.21

0.0

1.5

—

1.55

—

Other and unspecified drugs and medicaments

0.00

0.21

0.0

1.6

—

1.38

—

Elevated blood glucose level

0.00

0.21

0.0

1.1

—

1.32

—

Benign neoplasm of bone and articular cartilage

0.00

0.21

0.0

1.6

—

1.39

—

Allergic urticaria

0.00

0.21

0.0

1.6

—

1.45

—

Malignant neoplasm of pancreas, including Hilmo

0.00

0.21

0.0

1.2

—

1.29

—

Other peripheral vertigo

0.00

0.21

0.0

1.6

—

1.34

—

Neuromuscular dysfunction of bladder

0.00

0.21

0.0

1.5

—

1.44

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

0.00

0.21

0.0

1.5

—

1.33

—

Diseases of peritoneum

0.00

0.21

0.0

1.5

—

1.35

—

Enterocolitis due to Clostridium difficile

0.00

0.21

0.0

1.1

—

1.32

—

Family history of malignant neoplasm

0.00

0.21

0.0

1.6

—

1.23

—

Prepatellar bursitis

0.00

0.21

0.0

1.6

—

1.25

—

Kidney transplant status

0.00

0.21

0.0

1.5

—

1.40

—

Other osteochondropathies

0.00

0.21

0.0

1.5

—

1.35

—

Mental and behavioural disorders due to sedatives or hypnotics

0.00

0.21

0.0

1.5

—

1.51

—

Special screening examination for neoplasms

0.00

0.21

0.0

1.3

—

1.29

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

0.00

0.21

0.0

1.6

—

1.42

—

Perforation of tympanic membrane

0.00

0.21

0.0

1.1

—

1.37

—

Metatarsalgia

0.00

0.21

0.0

1.6

—

1.33

—

Hyperparathyroidism

0.00

0.21

0.0

1.5

—

1.31

—

Other problems related to primary support group, including family circumstances

0.00

0.21

0.0

1.5

—

1.45

—

Chronic viral hepatitis

0.00

0.21

0.0

1.5

—

1.57

—

Event of undetermined intent

0.00

0.21

0.0

1.5

—

1.48

—

Fall on and from ladder

0.00

0.21

0.0

1.5

—

1.34

—

Melanocytic naevi, other sites/unspecified

0.00

0.21

0.0

1.5

—

1.38

—

Vestibular neuronitis

0.00

0.21

0.0

1.5

—

1.38

—

Nail disorders

0.00

0.21

0.0

1.5

—

1.48

—

Other and unspecified visual disturbances

0.00

0.21

0.0

1.5

—

1.37

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

0.21

0.0

1.5

—

1.36

—

Disorders of parathyroid gland

0.00

0.20

0.0

1.5

—

1.27

—

Other viral hepatitis

0.00

0.20

0.0

1.4

—

1.59

—

Polypectomy (DHB20)

0.00

0.20

0.0

1.4

—

1.32

—

Care involving dialysis

0.00

0.20

0.0

1.4

—

1.39

—

Unspecified privation

0.00

0.20

0.0

1.5

—

1.44

—

Malignant neoplasm of head and neck

0.00

0.20

0.0

1.5

—

1.34

—

Abnormal findings on examination of blood, without diagnosis

102

0.80

0.20

1.6

1.2

1.26

1.36

—

102

Hyperlipidaemia, other/unspecified

1.25

0.20

1.3

1.2

1.30

1.37

—

Dental caries

1.18

0.19

1.2

1.1

1.47

1.40

—

Other arrhythmias

107

0.84

0.18

1.2

1.27

1.42

0.98

107

Autoimmune diseases excluding thyroid diseases

125

1.13

0.18

1.0

1.2

1.39

1.41

0.09

125

Diseases of arteries, arterioles and capillaries (FINNGEN)

0.73

0.17

1.4

1.3

1.50

1.44

—

Combinations of oral blood glucose lowering drugs

0.76

0.17

1.0

1.2

1.28

1.30

—

Bacterial pneumonia, not elsewhere classified

1.17

0.16

1.0

1.2

1.31

1.35

—

Other chronic obstructive pulmonary disease

0.78

0.15

1.0

1.3

1.32

1.30

—

COPD, hospital admissions

0.77

0.15

1.0

1.3

1.32

1.30

—

COPD, early/later onset

0.75

0.15

1.0

1.3

1.32

1.30

—

Primary gonarthrosis, bilateral

1.16

0.15

1.1

1.2

1.29

1.30

—

malignant neoplasm of male genital organs

1.18

0.15

1.1

1.3

1.33

1.37

0.20

Coxarthrosis, primary

0.82

0.14

1.1

1.2

1.57

1.30

—

Benign neoplasm: Colon

0.82

0.13

1.0

1.2

1.28

1.34

—

Unspecified haematuria

1.18

0.12

1.1

1.2

1.12

1.38

—

Benign neoplasm of colon, rectum, anus and anal canal

106

0.88

0.10

1.1

1.2

1.21

1.38

0.80

106

Autoimmune diseases excluding thyroid diseases, strict definition

120

1.09

0.10

1.0

1.3

1.40

0.02

120

Diabetic retinopathy

1.11

0.10

1.4

1.2

1.58

1.51

—

Pulmonary heart disease

1.14

0.10

1.2

1.3

1.44

1.38

—

Pulmonary embolism

1.14

0.10

1.2

1.3

1.44

1.37

—

Diaphragmatic hernia

1.06

0.09

1.2

1.3

1.18

1.29

—

Hypertensive diseases (excluding secondary)

1.13

0.09

1.2

1.3

1.41

1.42

0.03

Caries of dentine

1.05

0.09

1.2

1.1

1.42

1.40

—

Gonarthrosis [arthrosis of knee](FG)

100

1.09

0.09

1.2

1.42

1.38

0.17

100

malignant neoplasm of male genital organs, including Hilmo

1.13

0.08

1.1

1.3

1.33

1.37

0.18

Coxarthrosis, primary, with hip surgery

1.10

0.08

1.1

1.3

1.63

1.28

—

Aplastic and other anaemias

1.09

0.08

1.6

1.3

1.40

1.29

—

Disorders of vitreous body

0.84

0.07

1.0

1.3

1.23

1.30

—

Special screening examination for infectious and parasitic diseases

1.02

0.07

1.1

1.3

1.33

1.45

—

Malignant neoplasm of digestive organs, including Hilmo

0.84

0.07

1.1

1.3

1.43

1.36

—

Valvular heart disease excluding rheumatic fever

0.89

0.07

1.3

1.2

1.33

1.39

—

Coxarthrosis

0.87

0.06

1.1

1.2

1.57

1.38

—

Other chronic obstructive pulmonary disease, including avohilmo

0.88

0.06

1.0

1.2

1.27

1.35

—

Non-rheumatic valve diseases

0.90

0.05

1.3

1.2

1.33

1.39

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1.07

0.03

1.2

1.45

1.34

0.69

ILD medications: immunosuppressive drugs

123

0.96

0.00

1.0

1.3

1.50

1.37

0.86

123

Malignant neoplasm of prostate

1.04

0.00

1.1

1.3

1.30

1.35

—

Malignant neoplasm of prostate, including Hilmo

1.02

0.00

1.1

1.3

1.30

1.35

—

Fever of other and unknown origin

100

1.04

0.00

1.3

1.2

1.46

1.39

0.41

100

Hydrocephalus

0.00

0.0

1.1

—

1.20

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

0.00

0.0

2.0

—

1.55

—

Atrial fibrillation and flutter

0.94

0.00

1.0

1.3

1.41

1.44

—

Neuralgia and neuritis, unspecified

0.00

0.0

1.8

—

1.41

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

0.00

0.0

2.2

—

1.32

—

Dialysis

0.00

0.0

1.6

—

1.38

—

Occupational exposure to risk-factors

0.00

0.0

1.8

—

1.32

—

Endometriosis ASRM stages 1,2

0.00

0.0

1.0

—

1.06

—

Other diseases of the digestive system

0.98

0.00

1.4

1.3

1.50

1.35

—

Pedestrian injured in transport accident

0.00

0.0

1.7

—

1.40

—

Cramp and spasm

0.00

0.0

1.6

—

1.54

—

Burns and corrosions confined to eye and internal organs

0.00

0.0

1.8

—

1.45

—

Benign neoplasm: Skin of trunk

0.00

0.0

1.8

—

1.42

—

Other symptoms and signs involving the circulatory and respiratory systems

0.00

0.0

1.6

—

1.42

—

Malignant neoplasm of breast, including Hilmo

0.00

0.0

1.0

—

0.96

—

Contact with lifting and transmission devices, not elsewhere classified

0.00

0.0

2.0

—

1.46

—

Oxycodone

0.92

0.00

1.0

1.2

1.41

1.34

—

Mental retardation

0.00

0.0

2.0

—

1.38

—

Other anaemias

1.00

0.00

1.7

1.3

1.37

1.29

—

Periodontal disease, other/unspecified

0.00

0.0

2.0

—

1.38

—

Hepatic failure, not elsewhere classified

0.00

0.0

1.0

—

1.62

—

Acute alcohol intoxication ICD-9

0.00

0.0

2.0

—

1.35

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

0.00

0.0

1.1

—

1.32

—

Postpartum haemorrhage due to retained placenta

0.00

0.0

1.0

—

1.02

—

Burn and corrosion of head and neck

0.00

0.0

2.0

—

1.46

—

0.00

0.0

2.0

—

1.38

—

Specific development disorders of scholastic skills

0.00

0.0

2.0

—

1.52

—

Fibromyalgia

0.00

0.0

1.8

—

1.42

—

Primary hyperparathyroidism

0.00

0.0

1.9

—

1.27

—

Other juvenile arthritis

0.00

0.0

2.0

—

1.30

—

Oesophageal varices

0.00

0.0

1.2

—

1.30

—

Adenocarcinoma and ductal carcinoma of pancreas

0.00

0.0

1.2

—

1.24

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

-0.00

0.0

1.8

—

1.24

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

0.00

-0.00

0.0

1.2

—

1.10

—

Pulmonary heart disease, diseases of pulmonary circulation

1.02

-0.00

1.2

1.3

1.44

1.33

—

Glucagon-like peptide-1 (GLP-1) analogues

0.95

-0.00

1.0

1.2

1.44

1.34

—

Organic, including symptomatic, mental disorders

0.98

-0.00

1.4

1.3

1.37

1.26

—

Agoraphobia

0.00

-0.00

0.0

1.6

—

1.38

—

All dysplastic lesions of the cervix uteri, vagina or vulva

0.00

-0.00

0.0

1.0

—

1.09

—

Paralytic strabismus

0.00

-0.00

0.0

1.1

—

1.30

—

Polycystic ovarian syndrome, broad definition

0.00

-0.00

0.0

1.0

—

1.06

—

Non-small cell lung cancer, adenocarcinoma

0.00

-0.00

0.0

1.2

—

1.28

—

Other specified disorders of muscle

0.00

-0.00

0.0

1.8

—

1.50

—

Muscle strain

0.00

-0.00

0.0

1.9

—

1.51

—

COPD, hospital admissions 1, only main diagnosis

1.00

-0.00

1.0

1.3

1.38

1.29

—

Sicca syndrome [Sjögren]

0.00

-0.00

0.0

1.0

—

1.44

—

Myeloproliferative diseases (CML excluded)

0.00

-0.00

0.0

1.8

—

1.27

—

All dysplastic lesions of the cervix uteri

0.00

-0.00

0.0

1.0

—

1.09

—

Endometriosis ASRM stages 3,4

0.00

-0.00

0.0

1.0

—

1.06

—

HSIL lesion of the cervix uteri, vagina or vulva

0.00

-0.00

0.0

1.0

—

1.09

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.00

-0.00

0.0

1.8

—

1.48

—

COPD (mode)

0.97

-0.00

1.0

1.1

1.32

1.35

—

Transient ischemic attack

0.94

-0.00

1.3

1.2

1.47

1.30

—

Malignant neoplasm, without specification of site, including Hilmo

0.00

-0.00

0.0

1.2

—

1.08

—

Adenocarcinoma of pancreas

0.00

-0.00

0.0

1.2

—

1.24

—

Juvenile arthritis (FINNGEN)

0.00

-0.00

0.0

1.9

—

1.43

—

COPD related to multimorbidity

1.01

-0.00

1.0

1.3

1.32

1.25

—

Malignant neoplasm of oral cavity

0.00

-0.00

0.0

2.0

—

1.30

—

Barrett oesophagus

0.00

-0.00

0.0

1.7

—

1.28

—

Malignant neoplasm of pancreas

0.00

-0.00

0.0

1.1

—

1.36

—

Benign neoplasm of male genital organs

0.00

-0.00

0.0

2.0

—

1.38

—

Benign neoplasm: Cerebral meninges

0.00

-0.00

0.0

1.9

—

1.21

—

Benign neoplasm of meninges

0.00

-0.00

0.0

1.7

—

1.31

—

Carcinoma in situ, bladder

0.00

-0.00

0.0

1.2

—

1.04

—

Carcinoma in situ of cervix uteri

0.00

-0.00

0.0

1.0

—

1.10

—

Carcinoma in situ of other and unspecified digestive organs

0.00

-0.00

0.0

1.2

—

1.32

—

Carcinoma in situ of other and unspecified sites

0.00

-0.00

0.0

1.2

—

1.04

—

Carcinoma in situ of skin

0.00

-0.00

0.0

1.0

—

1.26

—

Cirrhosis of liver, NAS

0.00

-0.00

0.0

1.9

—

1.31

—

Status epilepticus

0.00

-0.00

0.0

1.8

—

1.40

—

Malignant neoplasm of oesophagus

0.00

-0.00

0.0

1.2

—

1.24

—

Lesion of radial nerve

0.00

-0.00

0.0

2.0

—

1.48

—

Generalized epilepsy

0.00

-0.00

0.0

1.8

—

1.45

—

Malignant neoplasm of eye, brain and central nervous system

0.00

-0.00

0.0

1.7

—

1.36

—

Septal defects

0.00

-0.00

0.0

1.1

—

1.51

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

0.00

-0.00

0.0

1.2

—

1.24

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

0.00

-0.00

0.0

1.0

—

0.94

—

Complications predominantly related to the puerperium

0.00

-0.00

0.0

1.0

—

1.09

—

Labour and delivery complicated by fetal stress [distress]

0.00

-0.00

0.0

1.0

—

1.27

—

Infections of genitourinary tract in pregnancy

0.00

-0.00

0.0

1.0

—

1.20

—

Pre-eclampsia

0.00

-0.00

0.0

1.0

—

1.08

—

Other and unspecified anaemias

1.01

-0.00

1.7

1.3

1.37

1.29

—

Pre-eclampsia or poor fetal growth

0.00

-0.00

0.0

1.0

—

1.14

—

Malignant neoplasm of breast, HER2-negative

0.00

-0.00

0.0

1.0

—

0.96

—

Maternal care for other conditions predominantly related to pregnancy

0.00

-0.00

0.0

1.0

—

1.24

—

Preterm labour and delivery

0.00

-0.00

0.0

1.0

—

1.24

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

0.00

-0.00

0.0

1.7

—

1.36

—

Pre-eclampsia or eclampsia

0.00

-0.00

0.0

1.0

—

1.08

—

Autoimmune hyperthyroidism

0.00

-0.00

0.0

1.8

—

1.32

—

Diffuse large B-cell lymphoma, including Hilmo

0.00

-0.00

0.0

1.2

—

1.24

—

Spirochaetal infections, other/unspecified

0.00

-0.00

0.0

1.7

—

1.36

—

Tuberculosis, wide, including avohilmo

0.00

-0.00

0.0

1.2

—

1.24

—

Malignant neoplasm of breast

0.00

-0.00

0.0

1.0

—

0.96

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

0.00

-0.00

0.0

1.0

—

0.96

—

Arthropathies in other diseases classified elsewhere

0.00

-0.00

0.0

1.8

—

1.52

—

Malignant neoplasm of brain, including Hilmo

0.00

-0.00

0.0

1.7

—

1.36

—

Malignant neoplasm of brain

0.00

-0.00

0.0

2.0

—

1.30

—

Extreme obesity with alveolar hypoventilation

0.00

-0.00

0.0

1.0

—

1.62

—

Mumps, including avohilmo

0.00

-0.00

0.0

1.0

—

1.52

—

Gestational [pregnancy-induced] hypertension

0.00

-0.00

0.0

1.0

—

1.10

—

Other specified/unspecified disorders of bone/cartilage

0.00

-0.00

0.0

1.0

—

1.47

—

Other and unspecified injuries of shoulder and upper arm

0.00

-0.00

0.0

1.0

—

1.58

—

Other or ill-defined heart diseases

0.00

-0.00

0.0

1.8

—

1.35

—

Other and unspecified mood [affective] disorders

0.00

-0.00

0.0

1.7

—

1.49

—

Alzheimer’s disease (Atypical or mixed)

0.00

-0.00

0.0

1.0

—

1.20

—

Impetigo

0.00

-0.00

0.0

1.8

—

1.55

—

Panniculitis affecting regions of neck and back

0.00

-0.00

0.0

1.0

—

1.48

—

Benign neoplasm: Descending colon

0.00

-0.00

0.0

1.1

—

1.26

—

Suppurative and necrotic conditions of lower respiratory tract

0.00

-0.00

0.0

1.8

—

1.38

—

Disorders resulting from impaired renal tubular function

0.00

-0.00

0.0

2.0

—

1.50

—

Sexual dysfunction

0.00

-0.00

0.0

2.0

—

1.38

—

Fitting and adjustment of other devices

0.92

-0.00

1.0

1.3

1.76

1.26

—

Human immunodeficiency virus [HIV] disease

0.00

-0.00

0.0

1.8

—

1.45

—

Right bundle-branch block

0.00

-0.00

0.0

1.2

—

1.33

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

-0.00

0.0

2.2

—

1.46

—

Implicit bacterial Sepsis

0.90

-0.00

1.1

1.3

1.53

1.31

—

Postpartum hemorraghe, parous women as controls

0.00

-0.00

0.0

1.0

—

1.02

—

Malignant neoplasm of digestive organs

0.99

-0.00

1.1

1.3

1.43

1.34

—

Postpartum hemorraghe, all women as controls

0.00

-0.00

0.0

1.0

—

1.14

—

!Aliquae complicationes praecoces traumatis

0.00

-0.00

0.0

1.7

—

1.53

—

Other orthopaedic follow-up care

0.00

-0.00

0.0

1.9

—

1.39

—

Diffuse large B-cell lymphoma

0.00

-0.00

0.0

1.2

—

1.24

—

Preparatory care for dialysis

0.00

-0.00

0.0

1.8

—

1.45

—

Artificial opening status

0.00

-0.00

0.0

1.8

—

1.34

—

Implicit bacterial Sepsis, including avohilmo

0.90

-0.00

1.1

1.3

1.48

1.33

—

Disorders of vitreous body and globe

0.96

-0.00

1.0

1.2

1.29

1.30

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

0.00

-0.00

0.0

1.1

—

1.34

—

Mental retardation, wide definition

0.00

-0.00

0.0

2.0

—

1.38

—

Eating disorder

0.00

-0.00

0.0

1.0

—

1.33

—

Scleritis and episcleritis

0.00

-0.00

0.0

1.8

—

1.48

—

Factors influencing health status and contact with health services

0.92

-0.00

1.7

1.1

1.63

1.42

—

Attention to artificial openings

0.00

-0.00

0.0

2.0

—

1.27

—

Human immunodeficiency virus [HIV] disease, including avohilmo

0.00

-0.00

0.0

1.7

—

1.43

—

Other maltreatment syndromes

0.00

-0.00

0.0

1.8

—

1.51

—

Unspecified misadventure during surgical and medical care

0.00

-0.00

0.0

1.6

—

1.54

—

Intentional self-harm by sharp object

0.00

-0.00

0.0

2.0

—

1.58

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

-0.00

0.0

1.7

—

1.46

—

Contact with sharp glass

0.00

-0.00

0.0

1.8

—

1.51

—

HSIL lesion of the cervix uteri

0.00

-0.00

0.0

1.0

—

1.09

—

Left bundle-branch block

0.00

-0.00

0.0

1.8

—

1.35

—

Contact with sharp object, undetermined intent

0.00

-0.00

0.0

1.8

—

1.51

—

Assault by unspecified means

0.00

-0.00

0.0

2.0

—

1.58

—

Assault by sharp object

0.00

-0.00

0.0

1.8

—

1.45

—

Tobacco use

0.00

-0.00

0.0

1.7

—

1.37

—

Injury of nerves at wrist and hand level

0.00

-0.00

0.0

1.8

—

1.52

—

Injury of muscle and tendon at forearm level

0.00

-0.00

0.0

2.0

—

1.38

—

Foreign body in alimentary tract

0.00

-0.00

0.0

1.8

—

1.42

—

Early complications of trauma

0.00

-0.00

0.0

1.7

—

1.53

—

Recurrent dislocation of patella

0.00

-0.00

0.0

1.8

—

1.38

—

Dislocation, sprain and strain of joints and ligaments of thorax

0.00

-0.00

0.0

1.0

—

1.55

—

Other disorders of urethra and urinary system

0.94

-0.00

1.3

1.2

1.25

1.32

—

Contusion of other and unspecified parts of foot

0.00

-0.00

0.0

1.9

—

1.57

—

Sequelae of injuries of neck and trunk

0.00

-0.00

0.0

1.8

—

1.55

—

Syncope and collapse

0.90

-0.00

1.1

1.2

1.36

1.35

—

Toxic effect of alcohol

0.00

-0.00

0.0

1.8

—

1.45

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

0.00

-0.00

0.0

2.2

—

1.58

—

Other diseases of pleura

0.92

-0.00

1.0

1.3

1.29

1.33

—

Haemorrhage, not elsewhere classified

0.00

-0.00

0.0

1.2

—

1.12

—

Ascites

0.00

-0.00

0.0

1.1

—

1.21

—

Abnormal serum enzyme levels

0.89

-0.00

1.0

1.2

1.27

1.34

—

Somnolence, stupor and coma

0.00

-0.00

0.0

2.2

—

1.50

—

Burn and corrosion of wrist and hand

0.00

-0.00

0.0

1.7

—

1.59

—

L02BG Aromatase inhibitors

0.00

-0.00

0.0

1.0

—

1.12

—

Burn and corrosion confined to eye and adnexa

0.00

-0.00

0.0

2.0

—

1.46

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.95

-0.00

1.0

1.2

1.44

1.34

—

Oedema, not elsewhere classified

0.94

-0.00

1.2

1.3

1.46

1.34

—

Other congenital malformations of face and neck

0.00

-0.00

0.0

1.8

—

1.42

—

Congenital malformations of cardiac septa

0.00

-0.00

0.0

1.1

—

1.55

—

Certain conditions originating in the perinatal period

0.00

-0.00

0.0

1.2

—

1.58

—

Malignant neoplasm of oesophagus, including Hilmo

0.00

-0.00

0.0

1.2

—

1.23

—

Postpartum haemorrhage

0.00

-0.00

0.0

1.0

—

1.27

—

Poor fetal growth

0.00

-0.00

0.0

1.0

—

1.10

—

Hodgkin lymphoma, hilmo

0.00

-0.00

0.0

2.0

—

1.54

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

0.00

-0.00

0.0

1.2

—

1.23

—

Multiple myeloma and malignant plasma cell neoplasms

0.00

-0.00

0.0

1.2

—

1.10

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

0.00

-0.00

0.0

1.8

—

1.45

—

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

0.00

-0.00

0.0

1.8

—

1.45

—

Spinal instabilities

0.00

-0.00

0.0

1.8

—

1.42

—

Autoimmune hepatitis, wide definition

0.00

-0.00

0.0

1.8

—

1.48

—

Myeloproliferative diseases

0.00

-0.00

0.0

1.8

—

1.28

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

-0.00

0.0

1.0

—

1.06

—

Retention of urine

0.93

-0.00

1.3

1.37

1.36

—

Thyroiditis

0.00

-0.00

0.0

1.0

—

1.56

—

Oesophagitis

0.00

-0.00

0.0

1.8

—

1.31

—

UC patients in KELA-register (code 208), prior to 1994

0.00

-0.00

0.0

1.9

—

1.31

—

Other pleural conditions

0.00

-0.00

0.0

1.1

—

1.29

—

Other inflammatory liver diseases

0.00

-0.00

0.0

1.7

—

1.40

—

Other diseases of stomach and duodenum

0.00

-0.00

0.0

1.2

—

1.17

—

Divergent concomitant strabismus

0.00

-0.00

0.0

1.6

—

1.54

—

GI-bleeding

1.00

-0.00

1.4

1.3

1.50

1.34

—

Other cataract

0.91

-0.00

1.2

1.45

1.36

—

Keratoconus

0.00

-0.00

0.0

2.0

—

1.36

—

Episcleritis

0.00

-0.00

0.0

1.8

—

1.48

—

Pyothorax

0.00

-0.00

0.0

1.2

—

1.30

—

Benign neoplasm: Long bones of lower limb

0.00

-0.00

0.0

1.0

—

1.48

—

Essential (haemorrhagic) thrombocythaemia

0.00

-0.00

0.0

2.2

—

1.12

—

Ulcerative enterocolitis

0.00

-0.00

0.0

1.7

—

1.47

—

Endocarditis

0.00

-0.00

0.0

1.8

—

1.33

—

Paralytic ileus

0.00

-0.00

0.0

1.0

—

1.38

—

Vascular disorders of the intestines

0.00

-0.00

0.0

1.0

—

1.41

—

Diffuse large B-cell lymphoma, helper endpoint

0.00

-0.00

0.0

1.2

—

1.24

—

Chronic ulcer of skin, not elsewhere classified

0.00

-0.00

0.0

1.1

—

1.29

—

Arterial embolism and thrombosis

0.00

-0.00

0.0

1.1

—

1.23

—

Mumps

0.00

-0.00

0.0

1.0

—

1.50

—

Post-traumatic wound infection, not elsewhere classified

0.00

-0.00

0.0

2.0

—

1.38

—

Optic neuritis

0.00

-0.00

0.0

2.0

—

1.54

—

Disorders of orbit

0.00

-0.00

0.0

1.2

—

1.30

—

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

0.00

-0.00

0.0

2.0

—

1.50

—

Chronic suppurative otitis media

0.00

-0.00

0.0

1.0

—

1.48

—

Acute peritonitis

0.00

-0.00

0.0

1.7

—

1.33

—

Unspecified jaundice

0.00

-0.00

0.0

1.1

—

1.11

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Testosterone Free/Testosterone.total in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS